The results of a study published in the June issue of the Journal of Clinical Endocrinology and Metabolism suggest an association between the use of low-dose...
In elderly type 2 diabetics with comorbid illness or functional impairment, the benefit of intensive glucose control to a maximum hemoglobin A1c of 7% (versus...
The International Agency for Research on Cancer (IARC) has announced that the implementation of smoke-free policies in many Western countries has reduced the...
New diabetes drugs should be subjected to studies to rule out cardiovascular risk, the FDA's Endocrinologic and Metabolic Drugs Advisory Committee decided at a...
Extracorporeal life support combined with conventional cardiopulmonary resuscitation (CPR) roughly doubles survival over CPR alone in patients with in-hospital...
A new study shows that the aggressive application of nationally recommended activities could prevent a high proportion of the coronary artery disease (CAD)...
Results of a small pilot trial showing that people with metabolic syndrome might benefit from an exercise regimen that includes aerobic interval training have...
A small but intriguing clinical trial has shown that atorvastatin (Lipitor, Pfizer) was no more effective than placebo in slowing the progression of...
With a decade of new data about risk factors for cardiovascular disease under its belt, the American Academy of Pediatrics (AAP) has issued new guidelines for...
Patients who are hospitalized for acute decompensated heart failure (ADHF) with a reduced LVEF should stay on beta blockers if they are already on them and, if...
A new analysis of data from the Framingham Heart Study shows that blood pressure (BP) levels in the community have improved over time, likely due to the...
Coronary heart disease has a significant impact on health-related quality of life, a new study shows [1]. Furthermore, there are big variations in quality of...
Plasma levels of copeptin, the C-terminal peptide fragment of a precursor to the antidiuretic and vasoconstricting hormone vasopressin, can predict long-term...
Using enoxaparin or heparin to bridge long-term anticoagulation therapy with warfarin for secondary stroke prevention has been associated with a high risk for...
Results of a meta-analysis indicate that the antiepileptic agent pregabalin is safe and effective for relieving pain in diabetic peripheral neuropathy (DPN). ...
Using enoxaparin or heparin to bridge long-term anticoagulation therapy with warfarin for secondary stroke prevention has been associated with a high risk for...
Merck and Schering-Plough presented interim results of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study today, a randomized, multicenter,...
Patients with coronary heart disease are more likely to show reduced cognitive function in late middle age than those without heart disease, a new study has...
Adding both more clarity and more confusion to a field already peppered with conflicting data, a new study has found that people who have migraine with aura...
The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial, a randomized, multicenter, placebo-controlled study evaluating the effects of combination...
If 100 patients referred for a primary-prevention implantable cardioverter defibrillator (ICD) based on a low LVEF, determined by any accepted method, had...
Doctors are doing a good job identifying patients with evolving MI presenting to the emergency department with chest pain but without ST segment elevation or...
Extremely obese patients are posing logistical and safety challenges for interventionalists, and many hospitals don't know what to do when it comes to treating...
If the US News & World Report rankings for cardiovascular care were Wimbledon, this year it would be the Cleveland Clinic in the role of Rafael Nadal--or Venus...
A new study has found that renal transplants in black patients appear to be more successful if the donor is black and has died of cardiac causes rather than...
A new study shows that in patients with early Alzheimer's disease (AD), better cardiorespiratory fitness is associated with less atrophy in regions of the...
FDA has approved its intravenous antihypertensive clevidipine (Cleviprex), which is the first new IV drug for high blood pressure in 10 years [1]. Clevidipine...
Many patients with heart failure would prefer to be on chronic medical therapy, which is likely to prolong survival at the cost of some quality of life, while...
The US FDA has approved the first combination of an angiotensin receptor blocker (ARB)--valsartan--with a calcium-channel blocker (CCB)--amlodipine--for the...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
